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Histidine phosphorylation (pHis) is well studied in
bacteria; however, its role in mammalian signaling
remains largely unexplored due to the lack of pHis-
specific antibodies and the lability of the phosphora-
midate (P-N) bond. Both imidazole nitrogens can
be phosphorylated, forming 1-phosphohistidine
(1-pHis) or 3-phosphohistidine (3-pHis). We have
developedmonoclonal antibodies (mAbs) that specif-
ically recognize 1-pHis or 3-pHis; they do not cross-
react with phosphotyrosine or the other pHis isomer.
Assays based on the isomer-specific autophosphor-
ylation of NME1 and phosphoglycerate mutase were
used with immunoblotting and sequencing IgG vari-
able domains to screen, select, and characterize
anti-1-pHis and anti-3-pHismAbs. Their sequence in-
dependence was determined by blotting synthetic
peptide arrays, and they have been tested for immu-
nofluorescence staining and immunoaffinity purifica-
tion, leading to putative identification of pHis-con-
taining proteins. These reagents should be broadly
useful for identification of pHis substrates and func-
tional study of pHis using a variety of immunological,
proteomic, and biological assays.INTRODUCTION
The majority of intracellular proteins are phosphorylated at any
given time, and, while 9 of the 20 amino acids can be phosphor-
ylated, the current focus has been on serine (Ser), threonine (Thr),
and tyrosine (Tyr) phosphorylation, despite histidine phosphory-
lation (pHis) having been first identified over 50 years ago (Boyer
et al., 1962). Ser, Thr, and Tyr all form acid-stable phosphoester
(P-O) bonds upon phosphorylation (Attwood et al., 2007),
whereas His forms heat and acid-labile phosphoramidate (P-N)
bonds. Phospho-specific antibodies have enabled routine study
of phosphoester protein phosphorylation, and the use of MS-
based phosphoproteomics has identified thousands of phos-
phorylation sites in human cells, tissues, and tumors. The lack198 Cell 162, 198–210, July 2, 2015 ª2015 Elsevier Inc.of specific antibodies with which to study pHis, and the relative
instability of the P-N bond under typical conditions used for pro-
teomics, havemade it impossible to determine the prevalence of
pHis. Early estimates suggest that pHis could be as abundant as
pTyr (Matthews, 1995; Pesis et al., 1988), which comprises1%
of all known phosphorylation in cells (Hunter and Sefton, 1980;
Olsen et al., 2006). Since current biochemical and proteomic
technologies have been optimized for preservation, enrichment,
and detection of the phosphoester amino acids, pHis has re-
mained largely invisible, and its importance has likely been
underestimated.
A large family of His kinases and downstream signaling pro-
teins, known as two-component regulatory systems, are widely
employed by bacteria to link extracellular signals with transcrip-
tion and chemotaxis. Similar phosphotransfer cascades function
in plants to regulate processes such as ripening and circadian
rhythms (Matthews, 1995). Its importance in these systems
notwithstanding, whether or not pHis plays an important role in
vertebrate cell signaling remains unresolved. NME1 and NME2
are the only mammalian protein-His kinases reported to date
(Cai et al., 2014; Hartsough et al., 2002; Wagner and Vu, 1995),
and there is growing evidence implicating these two closely
related proteins in cancer and tumor metastasis (Thakur et al.,
2011; Tso et al., 2013). Indeed, NME1 (aka Nm23-H1 or nucleo-
side diphosphate kinase, NDPK) was the first candidate metas-
tasis suppressor gene identified (Steeg et al., 1988). NME family
members are involved in intracellular nucleotide triphosphate
homeostasis and in both physiological and pathophysiological
cellular processes, such as proliferation, differentiation, devel-
opment, apoptosis, cytokinesis, and dynamin-mediated endo-
cytosis (Boissan et al., 2014; Conery et al., 2010). pHis is unique
among phosphoamino acids in that two biologically relevant iso-
mers occur. Both imidazole nitrogen atoms (N1 and N3) can be
phosphorylated to generate 1-phosphohistidine (1-pHis) or
3-phosphohistidine (3-pHis) (Figure 1A). NME family members
catalyze the transfer of phosphate from ATP onto NDPs through
a 1-pHis enzyme intermediate. 3-pHis is used by bacterial His ki-
nases to initiate phosphotransfer cascades and plays a role as
an enzyme intermediate for phospholipase D and for several
metabolic enzymes, including phosphoglycerate mutase
(PGAM), succinyl-CoA synthetase (SCS), and ATP-citrate lyase
(ACLY)(Kee and Muir, 2012). pHis regulatory sites have also
been identified in a number of proteins with non-enzymatic
Figure 1. Incorporation of Non-hydrolyzable Phosphohistidine Analogs into Degenerate Peptide Libraries for Use as Immunogens
(A) Structure of histidine and the two pHis isomers: 1-phosphohistidine (1-pHis) and 3-phosphohistidine (3-pHis).
(B) Structures of the three synthetic peptide libraries used in this study in which either His or a stable pHis mimetic (1-pTza or 3-pTza) is flanked by randomized,
neutral amino acids (alanine [A] and glycine [G)]). Each library is composed of 28 = 256 unique peptides (Figures S1A and S1B), acetylated at the N terminus and
containing L-cysteine (Cys) for chemical ligation to KLH (Ac-Cys.G/A.G/A.G/A.G/A.X.G/A.G/A.G/A.G/A-CONH2).
(C) The peptide libraries were conjugated to the carrier protein keyhole limpet hemocyanin (KLH). Three rabbits were immunized with the 3-pTza library (7302,
7303, and 7304), and three rabbits were immunized with the 1-pTza library (7305, 7306, and 7307).
See also Figure S1.functions. For example, phosphorylation of KCa3.1 (His358)
and TRPV5 (His711) by NME2 promotes channel activation
that is negatively regulated by a pHis-specific phosphatase
(PHPT1) (Cai et al., 2014; Srivastava et al., 2006). Phosphory-
lation of GNB1 (His266) by NME2 activates Gs and regulates
basal cAMP accumulation (Wieland et al., 2010). Histone H4
phosphorylation (His18) is highly conserved and was first
observed in eukaryotes over 40 years ago (Besant and Att-
wood, 2012).
Recently, sequence-specific pHis polyclonal antibodies to-
ward pHis18 in histone H4 have been generated (Kee et al.,
2010). First- and second-generation ‘‘pan-pHis’’ polyclonal an-tibodies against 3-pHis have also been reported (Kee et al.,
2013, 2015). However, these antibodies appear to be limited
in their usefulness by their cross-reactivity with pTyr. Iso-
form-specific pHis monoclonal antibodies (mAbs) have not
yet been developed. We used non-hydrolyzable phosphoryl-
triazolylalanine (pTza) pHis analogs (Kee et al., 2010; McAllis-
ter et al., 2011) incorporated into degenerate peptide libraries
to immunize rabbits and develop selective anti-1-pHis and
anti-3-pHis mAbs. We demonstrate that these mAbs do not
cross-react with pTyr, appear to detect pHis in a sequence-in-
dependent manner, and can be used in a variety of immuno-
logical assays.Cell 162, 198–210, July 2, 2015 ª2015 Elsevier Inc. 199
Figure 2. Screening of 1-pHis Antisera Us-
ing NME1 In Vitro Phosphorylation Assays
(A) Dot blot screening of 1-pHis antisera. The
1-pTza, 3-pTza, and His libraries (Figure 1B) were
dissolved in water, and 1 ml of 1:5 serial dilutions
were spotted directly on nitrocellulose and probed
with antisera from rabbits 7305, 7306, and 7307. A
synthetic pTyr peptide was included to control for
pTyr cross-reactivity, and membranes were pro-
bed with pTyr mAb 4G10 as a positive control.
(B) Ribbon representation of PDB ID code 1NSP.
NME1 was co-crystallized with ADP and Mg2+,
and the hydrogen bond between NME1 E129 with
theN3 nitrogen on the catalytic H118 is shown as a
dashed line.
(C) Phospho-NME1 (PDB ID code 4DY9) is shown
to highlight that 1-pHis (but not 3-pHis) is formed
on the catalytic His residue H118.
(D) NME1 and NME2 in vitro autophosphorylation
assay. Recombinant NME1 and NME2 were
incubated with up to 1 mM ATP at RT for 10 min.
Negative controls were performed by omitting ATP
or treating with 1 M HCl for 15 min at 37C.
Immunoblotting was performed with antiserum
from rabbit 7305, and an identical gel was run in
parallel and stained with Coomassie blue.
(E) 1-pHis detection limit assay. In-vitro-phos-
phorylated NME1was diluted from 200 to 5 ng and
blotted with 1-pHis antisera from rabbits 7305 and
7306, as well as NME1 antibodies. Identical gels
were stained with Coomassie blue.
(F) 1-pHis isoform specificity. Recombinant PGAM
(Figure 3E) and NME1 were autophosphorylated
in vitro and blotted with 1-pHis antisera (rabbit
7305).
(G) Phospho-NME1 spot blots. In vitro phos-
phorylation of NME1 was performed as in Fig-
ures 2D and 2E, except reactions were stopped
with the addition of 2% SDS (rather than sample buffer), treated with or without heating to 95C for 10 min, diluted 1:5, and spotted directly on
nitrocellulose. Representative immunoblots with mAb SC1-1 and NME1 antibodies are shown.
See also Figures S1 and S2.RESULTS
Design of pHis mAb Immunogens: Incorporation
of Non-hydrolyzable pHis Analogs into Degenerate
Peptide Libraries
Previous attempts to make pHis antibodies using pHis itself as
the antigen have been unsuccessful, presumably because the
labile phosphoramidate bond is hydrolyzed too rapidly after im-
munization to elicit an immune response. The development of
non-hydrolyzable phosphonate analogs of both isomers
(1-phosphoryl-triazolylalanine [1-pTza] and 3-phosphoryl-triazo-
lylalanine [3-pTza]) allowed us to develop a strategy for gener-
ating both 1-pHis- and 3-pHis-specific mAbs. We synthesized
two peptide libraries consisting of 1-pTza or 3-pTza flanked by
randomized sets of alanine (Ala) and glycine (Gly) to serve as im-
munogens. An unphosphorylated version with His in place of
pTza was also synthesized (Figure 1B). MS analysis of the pep-
tide libraries confirmed that the random incorporation of Ala
and Gly matched the expected distribution of peptides sharing
the same composition of 0–8 Ala and/or Gly residues (Figures
S1A and S1B). The N-terminal Cys was used to couple the200 Cell 162, 198–210, July 2, 2015 ª2015 Elsevier Inc.pTza libraries to KLH (keyhole limpet hemocyanin), and three
rabbits were immunized for each pHis isomer (Figure 1C).
Development of Phospho-NME1 Screening Assay
Demonstrates 1-pHis Antibody Specificity
Bleeds from immunized rabbits (7305, 7306, and 7307) were
screened by dot blot using the 1-pTza library. To define pHis iso-
form specificity and control for cross-reactivity, the 3-pTza pep-
tide library, a His control library, and a pTyr peptide (Nck pY105)
were also included (Figure 2A). Antisera from two rabbits (7305
and 7306) detected only the 1-pTza immunizing library and did
not cross-react with pTyr. While the synthetic pTza immunogen
peptides were useful for preliminary antisera screening, protein
samples with pure 1-pHis or 3-pHis were needed for screening
antibodies for isomer specificity. Two in vitro phosphorylation
assays capable of rapidly generating either pure 1-pHis or
3-pHis on proteins were developed using NME1/NME2 and
PGAM, respectively. To generate 1-pHis, we utilized the unique
properties of NME1/2, which autophosphorylate on a conserved
catalytic His (H118) when incubated with ATP andMg2+. This oc-
curs solely at the N1 position due to a conserved Glu (E129) that
H bonds with the protonated N3 nitrogen, leaving N1 able to
accept the g-phosphate from ATP (PDB ID codes 1NSP and
4DY9; Figures 2B and 2C) (More´ra et al., 1994). Autophosphory-
lation of recombinant NME1/2 occurred in an ATP dose-depen-
dent fashion up to 1 mM ATP (Figure 2D). Reactions were
stopped by addition of 53 sample buffer (pH 8.8) and immedi-
ately analyzed by amodified SDS-PAGEmethodwithout heating
(Supplemental Experimental Procedures). Autophosphorylation
on H118 was confirmed by liquid chromatography-tandem
mass spectrometry (LC-MS/MS) with modifications to preserve
and detect pHis (Figure S1C; Supplemental Experimental Proce-
dures). Analysis by immunoblotting and Coomassie staining re-
vealed a phosphorylation-dependent doublet (for NME1 though
not NME2) with the slower migrating band representing phos-
pho-NME1 (pNME1). 1MHCl acid treatment at 37C or omission
of ATP reduced or abolished phosphorylation of NME1 (Fig-
ure 2D). Mutagenesis of the catalytic residue H118 prevented
phosphorylation of NME1/2 (data not shown).
In-vitro-phosphorylated NME1 was used to measure the
sensitivity of 1-pHis antisera (Figure 2E) and gauge titer as rab-
bits were boosted with antigen until titers peaked and stabilized.
Identical samples were blotted with NME1 antibodies or stained
by Coomassie as a loading control. Interestingly, 1-pHis was de-
tected by rabbit 7305 antisera, but not by 7306 (Figure 2E),
despite both binding 1-pTza peptides (Figure 2A). We also
confirmed that 1-pHis antisera did not cross-react with 3-pHis.
In-vitro-phosphorylated PGAM (pPGAM) was analyzed along-
side 5- to 125-fold less NME1 (Figure 2F), and no 3-pHis signal
was observed. Identical samples blotted with 3-pHis antisera
(Figure 3F) served as a positive control for pPGAM detection. A
method for rapid analysis of pHis was also developed for
screening. pNME1 or pPGAM were directly spotted onto nitro-
cellulose to avoid potential loss of signal that may occur during
SDS-PAGE. This allowed for comparison of mAb sensitivity by
spotting limiting dilutions of the phosphoproteins. 1-pHis mAb
SC1-1 was able to detect less than 600 pg of pNME1, and the
signal was abolished when samples were heated at 95C for
10 min to induce dephosphorylation, whereas NME1 detection
was unaffected (Figure 2G).
Development of Phospho-PGAM Screening Assay
Demonstrates 3-pHis Antibody Specificity
Bleeds from 3-pTza-immunized rabbits (7302, 7303, and 7304)
were screened by dot blot (as described for 1-pTza antisera; Fig-
ure 2A), and only the 3-pTza immunizing library was detected
(Figure 3A). PGAM is a glycolytic enzyme that converts 3-phos-
phoglycerate to 2-phosphoglycerate through a 3-pHis phos-
phoenzyme intermediate (Vander Heiden et al., 2010). Available
crystal structures of pPGAM and PGAM co-crystallized with its
phosphate donor (2,3-diphosphoglycerate [2,3-DPG]) show
that only N3 of H11 is positioned to accept the phosphate from
2,3-DPG (PDB ID codes 1E58 and 2H4z; Figures 3B and 3C).
To determine if PGAM could be phosphorylated in vitro, gluta-
thione S-transferase (GST)-PGAM was incubated with 2,3-
DPG (1 mM to 1 mM) (Figure 3D). Identical samples were heated
at 95C for 10 min, and immunoblotting with 3-pHis antisera
revealed a heat-sensitive, 45 kDa band that was absent when
2,3-DPG was omitted. PGAM was subsequently cloned into abacterial expression vector that allowed cleavage of the GST
for analysis of untagged protein. PGAM was purified from
Escherichia coli and incubated with or without 2,3-DPG. Auto-
phosphorylation on H11 was confirmed by LC-MS/MS (Fig-
ure S1D), and immunoblotting with 3-pHis antisera revealed a
heat-sensitive band at 25 kDa (Figure 3E) that was abolished
by mutagenesis of H11 (data not shown).
To confirm that 3-pHis antisera did not cross-react with
1-pHis, pNME1 was analyzed alongside pPGAM, and no
1-pHis signal was detected (Figure 3F). As we observed
for 1-pHis antisera, not all 3-pHis antisera that recognized the
pTza analogs could bind pHis. Antisera from rabbits 7303 and
7304 (Figure 3F), but not from 7302, detected pPGAM. For this
reason, we used splenocytes from rabbits 7303 and 7304 to
generate hybridomas expressing 3-pHis mAbs in collaboration
with Epitomics. To determine 3-pHis mAb sensitivity, in-vitro-
phosphorylated PGAM was spotted directly on nitrocellulose.
A representative immunoblot with 3-pHis mAb SC39-4 showed
phospho-PGAM was detected down to 10 ng in a heat-sensi-
tive manner (Figure 3G).
Screening and Sequencing of 1-pHis mAb Hybridomas
Yielded Three Unique Sequence-Independent mAbs
Splenocytes from rabbit 7305 were used for generation of
1-pHis hybridomas, as described for 3-pHis hybridomas.
Several thousand hybridoma cell lines generated from rabbit
7305 were initially screened by ELISA in 96-well plates coated
with the immunizing 1-pTza peptide library (data not shown).
48 ELISA-positive multiclonal cell lines were selected for sec-
ondary screening using several assays, including the pNME1
assays described above. Since pHis is known to be involved
in bacterial two-component signaling, we also developed a bac-
terial-based screening assay in which E. coli transformed with a
pGEX-NME1 plasmid were induced with isopropyl b-D-1-thio-
galactopyranoside (IPTG) for 3 hr to overexpress the 1-pHis-
positive control protein GST-NME1. Crude lysates were loaded
on preparative minigels (i.e., a single sample well) and trans-
ferred to polyvinylidene fluoride (PVDF) membranes, which
were clamped into a slot blotting apparatus (Supplemental
Experimental Procedures). Membranes were probed with cell
supernatants from the 48 ELISA-positive multiclonal lines (Fig-
ure S2A). The top three multiclonal cell cultures (MC1, MC50,
and MC77) were selected for subcloning based on multiple as-
says (ELISA, immunoblotting, peptide dot blots, etc.). Similar
assays were used to screen subclones for the final selection
of 1-pHis mAb hybridoma cell lines. For example, small-scale
screens were performed using E. coli lysates treated with or
without heat (Figure S2B). Identical membranes were probed
with crude 1-pHis antisera, and the 1-pHis mAbs exhibited
significantly decreased background. Since GST-NME1 is highly
overexpressed in these cells, it is not surprising that it was the
strongest signal detected; however, many other heat-sensitive
bands were also detected (Figure S2B). Next, we sought to
determine the extent to which these mAbs could detect
1-pHis in mammalian cells, by performing a similar screen using
lysates from a stably transfected FLAG-NME1 293 cell line (Fig-
ure S2C). Membranes were probed simultaneously with FLAG-
M2 and 1-pHis mAbs (Figure S2D). Multiple heat-sensitiveCell 162, 198–210, July 2, 2015 ª2015 Elsevier Inc. 201
Figure 3. Screening of 3-pHis Antisera by PGAM In Vitro Phosphorylation Assays
(A) Dot blot screening of 3-pHis antisera from rabbits 7302, 7303, and 7304 was performed as described in Figure 2A.
(B) Ribbon representation of PDB ID code 4HZE shows the relative positions of N1 and N3 in H11 of PGAM and its phosphate donor 2,3-DPG.
(C) Structure of PGAM (PDB ID code 1E58) highlighting 3-pHis formation on the catalytic His residue H11.
(D) GST-PGAM fusion protein was autophosphorylated in vitro by addition of increasing concentrations of 2,3-DPG. Reactions were stopped by the addition of
53 sample buffer (pH 8.8) and treated with or without heating to 95C for 10 min.
(E) Purified PGAM was autophosphorylated in vitro by incubation with 2,3-DPG for 10 min at 30C. Reactions were stopped by addition of 53 sample buffer
(pH 8.8) and treated with or without heat.
(F) 3-pHis isoform specificity. Recombinant NME1 and PGAMwere autophosphorylated in vitro by incubationwith ATP or 2,3-DPG, respectively, and blottedwith
3-pHis antisera from rabbits 7303 and 7304.
(G) Phospho-PGAM spot blots. In vitro phosphorylation of PGAM was performed as in Figure 3E, except reactions were stopped by the addition of 2% SDS.
Reactions were treated with or without heat, diluted 1:5, and spotted directly on nitrocellulose. A representative immunoblot with 3-pHis mAb SC39-4 is shown.
See also Figures S1 and S2.bands were detected, further suggesting that 1-pHis mAbs are
able to detect 1-pHis regardless of sequence context.
Sequencing of the immunoglobulin G (IgG)-variable domains
(VH and VL) revealed that three unique sequences were encoded
by subclones SC1-1, SC50-3, and SC77-11.202 Cell 162, 198–210, July 2, 2015 ª2015 Elsevier Inc.Screening and Sequencing of 3-pHis mAb Hybridomas
Yielded Three Unique Sequence-IndependentmAbs and
One Sequence-Dependent mAb
Hybridomas generated from combined splenocytes from rabbits
7303 and 7304 were screened by ELISA using the 3-pTza
peptide library (data not shown). 30 ELISA-positive multiclonal
cell lines were selected for secondary screening using 3-pHis-
specific assays, including pPGAM as described above. The
four best 3-pHis mAb cell lines (MC39, MC44, MC56, and
MC60) were subcloned, resulting in up to 12 ELISA-positive sub-
clones from each parental multiclone. E. coli transformed with a
pGEX-PGAM plasmid were induced, and crude lysates were
supplemented with 2,3-DPG, spiked with purified, untagged
PGAM, and loaded on preparative minigels. High-throughput,
slot blotting was performed as described for 1-pHis mAb hybrid-
omas (Figure S2E).
A small-scale screen was performed in parallel using identical
E. coli lysates treated with and without heat (Figure S2F). All of
the detected bands were heat sensitive, indicating the mAbs
are 3-pHis-specific. Strong signals for the positive control pro-
teins, GST-PGAM and PGAM (untagged), as well as many other
heat-sensitive bands, were detected by SC39s, SC56s, and
SC60s, suggesting that these mAbs lack strong sequence spec-
ificity but do not produce an identical pattern of bands. In
contrast, SC44s primarily detected a strong band corresponding
to bacterial SCS (Figures S2E and S2F). SCS also uses a 3-pHis
phosphoenzyme intermediate (Fraser et al., 2000), and SC44s
detected both bacterial SCS and mammalian SCS and ACLY
(Figure S2G), which share the sequence motif G-H-A-G-A (Fig-
ure S2H). Cell lysates prepared from a stably transfected
HEK293 cell line expressing FLAG-NME1 were blotted with
3-pHis mAb SC39-4, and 3-pHis on endogenous pPGAM was
detected, but not 1-pHis on FLAG-NME1, indicating the 3-pHis
mAbs do not cross-react with 1-pHis generated in vivo (Fig-
ure S2I). Sequence analysis of 3-pHis mAb VH and VL domains
allowed us to identify SC39-4, SC56-2, and SC60-2 as unique,
sequence-independent 3-pHis mAbs, as well as a distinct
sequence-dependent mAb SC44-8 that has bias toward the
A/G motif present in SCS and ACLY.
1-pHis and 3-pHis Antibodies Detect Various pTza
Peptides of Defined Sequence
Synthetic 1-pTza and 3-pTza peptide dot blot arrays were used
to confirm the pHis isoform specificity of the pHis mAbs and
determine if they have any local amino acid sequence specificity.
We synthesized peptides of a defined sequence based on the
best-characterized mammalian pHis proteins: ACLY, NME1,
PGAM, histone H4, KCa3.1, and GNB1. Peptides corresponding
to the pHis sites in these proteins were synthesized with His,
1-pTza, or 3-pTza, flanked by four amino acids on either side
(Figure S3; Table S2). Serial dilutions of each defined-sequence
peptide, the immunizing pTza, and the control His peptide li-
braries were spotted onto nitrocellulose and blotted with affin-
ity-purified, polyclonal 1-pHis, or 3-pHis antibodies. The 3-pHis
antibodies bound only the 3-pTza peptides, and the 1-pHis anti-
bodies bound only the 1-pTza peptides, regardless of sequence
(Figure 4A). Identical membranes were probedwith 1-pHismAbs
as part of our screening process to select mAbs with the broad-
est sequence recognition (Figure 4B). The 1-pHis mAbs dis-
played similar binding profiles and detected as little as 1 ng of
the NME1/2 H118 peptide. Each of the 1-pTza peptides tested
was detected, suggesting thesemAbswill be useful for detecting
1-pHis in a broad range of sequence contexts. Since 3-pHismAbs did not cross-react with either 1-pTza or His peptides (Fig-
ure 4A), we probed peptide arrays consisting of just 3-pTza pep-
tides, including a PGAM peptide, to determine their sequence
specificity (Figure 4C). In contrast to the 1-pHis mAbs, the
3-His mAbs displayed some variation in binding profiles.
3-pHis mAb SC39-4 was able to detect all 3-pTza peptides
down to 800 pg; however, binding to the KCa3.1 peptide was
relatively poor (100 ng). 3-pHis mAb SC56-2 showed similar
binding characteristics; however, it was better at detecting the
KCa3.1 peptide (4 ng), while being worse at binding the GNB1
peptide. SC44 detected the A/G motif peptide (based on
ACLY) and the immunizing peptide library down to 160 and
800 pg, respectively, confirming its sequence bias.
pHis mAbs Do Not Cross-React with pTyr Peptides
Since some of the first described pTyr mAbs cross-reacted with
pHis (Frackelton et al., 1983), and recently reported polyclonal
pHis antibodies displayed only a 10-fold higher selectivity
for pHis over pTyr (Kee et al., 2013), we tested our pHis mAbs
for cross-reactivity using synthetic pTyr peptides. Serial dilutions
of pTyr peptides (Nck and the Eck/EphA2 and FAK tyrosine ki-
nases) were spotted on nitrocellulose along with their unphos-
phorylated counterparts. The pTyr mAb 4G10 detected only
the pTyr peptides (Figure 4D), whereas none of the peptides
were detected by 3-pHis (Figure 4E) or 1-pHis mAbs (Figure 4F).
pHismAbsDoNot Cross-Reactwith pTyr Proteins in Cell
Lysates
To test for pTyr cross-reactivity of our pHis mAbs on cell lysates,
cultures of v-Src-transformed NIH/3T3 fibroblasts (psrc11;
Johnson et al., 1985) were pre-incubated with 1 mM orthovana-
date for 30 min to enhance pTyr signals. Non-transformed fibro-
blasts (pancreatic stellate cells PaSC) were tested in parallel as a
negative control. To preserve pHis in cell lysates for analysis by
immunoblotting, we adopted a modified SDS-PAGE method to
maintain the sample pH above 8 to stabilize pHis (Supplemental
Experimental Procedures). As expected, pTyr mAb 4G10 de-
tected an elevated signal in the psrc11 cells, but not in the
PaSC-negative control cells, but neither the 1-pHis nor 3-pHis
mAbs detected the elevated pTyr signal in psrc11 cells
(Figure 5A).
pHis mAbs Detect pHis Proteins in Mammalian Cell
Lysates
A number of heat-sensitive bands were detected in the psrc11
and PaSC lysates by 1- and 3-pHis mAbs. Next, we immuno-
blotted lysates from a variety of other mammalian cell lines to
characterize the pHis levels in different cell types. 3-pHis
mAbs SC39-4 (Figure 5B) and SC44-8 (Figure 5C) were used
to blot lysates from 293 cells, and 1-pHis mAb SC1-1 was
used to blot lysates from several pancreatic cancer (PC) cell
lines and HPDE6, a normal pancreatic epithelial cell line (Fig-
ure 5D). Common patterns of heat-sensitive bands were
observed, indicating many proteins in these cancer cell lines
are similarly regulated by 1-pHis modification. Lysates from
FLAG-NME1 293, HeLa, C2C12, and NME1- and NME2-overex-
pressing (OE) melanoma cell lines (Hamby et al., 2000) were
also blotted with 1-pHis mAb SC1-1 (Figure 5E). 1-pHis wasCell 162, 198–210, July 2, 2015 ª2015 Elsevier Inc. 203
Figure 4. 1-pHis and 3-pHis mAbs Detect Isomer-Specific pTza Peptides, but Not pTyr
(A and B) Synthetic peptide dot blot arrays consisting of the His, 1-pTza, or 3pTza libraries (Figure 1B) and a pTyr (NCK) peptide, and peptides with His, 1-pTza, or
3pTza incorporated into defined sequences (based on the pHis protein substrates: ACLY, NME1/2, histone H4, KCa3.1, and GNB1) were spotted on nitrocel-
lulose and probed with (A) affinity-purified polyclonal 3-pHis (7303) or 1-pHis (7305) antibodies or (B) 1-pHis mAbs SC1-1, SC50-3, and SC77-11.
(C) 3-pTza peptide dot blot characterization of 3-pHis mAbs. A partially deprotected, mono-ethyl ester version of the ACLY-based peptide (AGAG-mono-Et-3-
pTza-AGAG) was also included. (A–C) The layout of spotted peptide dilutions (500–0.16 ng) are shown in gray boxes. The peptide sequences and their sources
are indicated to the left of the peptide layouts.
(D–F) Synthetic pTyr peptide dot blots. Peptides based onNck, Eck, and FAKwere spotted on nitrocellulose and probedwith (D) pTyrmAb 4G10, (E) 3-pHismAbs
SC39-4, SC44-8, and SC56-2, or (F) 1-pHis mAbs SC1-1 and SC50-3.
See also Figure S3.detected on NME family members in mouse, human, and bac-
terial cells, including NME1, NME2, NME4, NME5 (Figures
S4A–S4C), and NME7 (data not shown), despite differing se-
quences flanking the pHis residue (Figure S4A), as well as the
E. coli NME1 homolog NDK (Figure S4C). While the major
pHis proteins detected appear to be known enzymes (i.e.,
NME1/2 [1-pHis], PGAM, SCS, and ACLY [3-pHis]), the detec-
tion of many unidentified, heat-sensitive bands, particularly by204 Cell 162, 198–210, July 2, 2015 ª2015 Elsevier Inc.the 3-pHis mAbs, suggests they will be useful in identifying
many pHis substrates.
Immunofluorescence Staining Reveals Association
of 1-pHis with the Outer Membrane of Phagosomes
To test the ability of these mAbs to detect pHis proteins by
immunofluorescence staining, HeLa cells were stained with the
1-pHis mAb SC1-1. We observed a distinct staining pattern in
Figure 5. pHis, but Not pTyr, Proteins Are Detected in Mammalian
Cells
(A) Src-transformed and non-transformed fibroblast cell lines (psrc11) and
pancreatic stellate cells (PaSCs) were analyzed by immunoblotting with pTyr,
1-pHis, or 3-pHis mAbs. Cells were pre-treated with 1 mM sodium orthova-
nadate for 30 min prior to lysis.
(B and C) HEK293 cell lysates were immunoblotted with 3-pHis mAbs SC39-4
and SC44-8.
(D and E) Pancreatic cancer cell lysates, FLAG-NME1 293, HeLa, C2C12, and
NME1- or NME2-overexpressing (OE) melanoma cells were immunoblotted
with 1-pHis mAb SC1-1. All lysates (A–E) were prepared by scraping cells into
23 sample buffer (pH 8.8) and treated with or without heating for 10 min.
See also Figure S4.which most cells had a large (1–2 mm) compartment that stained
strongly in the surrounding region but lacked interior pHis stain-
ing (Figure 6A). We surmised that thesemight be acidic compart-
ments, such as phagosomes or autophagosomes, and pro-
ceeded to test this hypothesis by using primary murine
macrophages to look for specific staining of phagosomes. Mac-
rophages isolated from bone marrow were incubated with fluo-
rescently labeled dextrans to track internalization into phago-
somes. Cells were also incubated with LysoTracker prior to
fixation to label acidic compartments. 1-pHis staining was
absent in nuclei, as well as the interior of phagosomes in macro-
phages co-labeled with the internalized dextrans and Lyso-
Tracker, but staining was pronounced in the regions surrounding
these compartments (Figures 6B–6D). Remodeling of the actin
cytoskeleton supports the extension of pseudopodia at sites of
particle engulfment and F-actin assembles around nascent
phagosomes. Co-staining with mAb SC1-1 and phalloidin-
TRITC revealed a lack of co-localization of 1-pHis with actin fila-
ments (Figure 6E).
3-pHis mAb Immunofluorescence Reveals Staining
of Centrosomes, Spindle Poles, and Midbodies
Macrophages stained with 3-pHis mAbs displayed a pattern
distinct from 1-pHis staining. Punctate structures were observed
throughout the cytosol; however, no co-localization was
observed when antibodies specific for organelle markers (e.g.,
ATP synthase, LC3, Rab5, a-tubulin, and LAMP1; Figures
S5A–S5B; data not shown) were tested for co-staining. In
contrast to macrophages, staining of HeLa cells with 3-pHis
mAbs was primarily nuclear (though curiously absent from
nucleoli), and distinctive cell-cycle-dependent patterns were
observed. Prometaphase cells through telophase cells dis-
played remarkable 3-pHis staining of spindle poles (Figures
6F–6K). Interphase cells displayed staining of centrosomes,
and cells in prophase were observed with duplicated centro-
somes (Figure 6G). An apparent burst of 3-pHis signals was
observed in dividing cells, and this seemed to last from prome-
taphase through anaphase. To confirm this observation, HeLa
cells were co-stained with 3-pHis mAbs and spindle pole
markers Aurora-A and g-tubulin (Figures 6H and 6I). To demon-
strate that 3-pHis mAbs stained primarily spindle poles, and not
spindles, cells were co-stained with a-tubulin (Figure 6J). 3-pHis
mAbs also stained structures devoid of Aurora-A, g-tubulin, and
a-tubulin in both HeLa and U2Os cells, and these appeared to
be the midbody of cells in late telophase. (Figures 6H–6K andCell 162, 198–210, July 2, 2015 ª2015 Elsevier Inc. 205
Figure 6. 1-pHis mAbs Negatively Stain Macrophage Phagosomes, and 3-pHis mAbs Stain Centrosomes and Spindle Poles in HeLa Cells
(A) HeLa cells were fixed with PFA and stained with 1-pHis mAb SC1-1. White arrows indicate acidic compartments.
(B) Macrophages were fed Dextran-AF488 and labeled with LysoTracker for 60 min prior to fixation with PFA, and staining with 1-pHis mAb SC1-1 was detected
by Cy5-conjugated secondary antibodies. Scale bar, 10 mm.
(C) Macrophages were incubated with Dextran-AF488 for 60 min, and staining with mAb SC1-1 was detected by Cy5-conjugated secondary antibodies.
(D) Macrophages were labeled with LysoTracker for 60 min prior to fixation, andmAb SC1-1 staining was detected by AF-488-conjugated secondary antibodies.
(E) Co-staining of macrophages with mAb SC1-1 and Phalloidin-TRITC.
(F–K) HeLa cells were fixed with PFA (F and G) or pre-permeabilized with 0.5% Triton X-100 and fixed with PFA (I) and (K) or methanol (H) and (J) and stained with
3-pHis mAb SC39-4 alone (F and G) or co-stained with Aurora A (H), g-tubulin (I), or a-tubulin (J and K) antibodies. (F) Metaphase cells are shown in an expanded
view in the right panel. (G) From left to right, interphase, early prophase, and anaphase cells are shown. (H–K) Cells in metaphase, prometaphase, and telophase
are shown. White arrows indicate centrosomes and spindle poles, and yellow arrows indicate midbodies in telophase cells. Nuclei were visualized with DAPI.
Scale bar, 20 mm.
See also Figure S5.S5C–S5E). A series of negative controls using the immunizing
pTza peptide libraries were performed. Only the 1-pTza peptides
could block 1-pHis staining (Figures S5F–S5I and S5P–S5Q),
while only the 3-pTza peptides could block 3-pHis staining (Fig-
ures S5K–S5N and S5R–S5S). Additionally, boiling slides for
10 min in citrate buffer reduced both 1-pHis and 3-pHis staining
(Figures S5J and S5O).206 Cell 162, 198–210, July 2, 2015 ª2015 Elsevier Inc.Enrichment and Identification of Proteins by pHis mAb
Immunoaffinity Purification and SILAC LC-MS/MS
Traditional immunoprecipitation methods are not amenable to
pHis preservation and detection. A method for immunoaffinity
purification of pHis substrates using immobilized pHis mAbs
was developed. Reusable pHis mAb resins were packed in chro-
matography columns and used to enrich pHis phosphoproteins
Table 1. SILAC Ratios Determined by LC-MS/MS Analysis Indicate Enrichment of Known pHis Proteins by pHis mAb Immunoaffinity
Purification
Protein Sequence Site 1-pH E1 1-pH E2 3-pH E1 3-pH E2
NME1a QVGRNIIHGSDSVES H118 15.05 51.86 3.18 2.14
NME2a QVGRNIIHGSDSVKS H118 15.59 55.96 3.46 –
NME4 HISRNVIHASDSVEG H151 – – – –
NME5b DDLRNALHGSNDFAA H127 – – – –
NME6b TDTRNTTHGSDSVVS H129 – – – –
NME7 DGIRNAAHGPDSFAS H206 – – – –
Histone H4a GKGGAKRHRKVLRDN H18 19.14 9.8 22.82 17.9
KCa3.1b FRQVRLKHRKLREQV H358 – – – –
TRPV5b LRQNTLGHLNLGLNL H711 – – – –
GNB1a QELMTYSHDNIICGI H226 – – – 1.21
PGAM YKLVLIRHGESAWNL H11 – 4.25 4.01 2.44
ACLY SSEVQFGHAGACANQ H760 5.29 7.2 11.62 2.99
SCS PPGRRMGHAGAIIAG H299 – 1.68 – –
P-Selectinb GKCPLNPHSHLGTYG H771 – – – –
TUBBa GNNWAKGHYTEGAEL H105c 3.55 4.49 4.33 2.09
TCP1a EETERSLHDAIMIVR H346c 6.10 5.99 5.98 3.20
YWHABa KTALCFRHLMKQLLN H202c – 2.04 7.43 1.63
LDHAa GEMMDLQHGSLFLRT H67c 4.18 6.50 6.60 3.08
RPS3A LGKLMELHGEGSSSG H232c 7.21 9.10 10.41 4.98
GAPDH TMEKAGAHLQGGAKR H111c 3.40 4.45 4.76 3.32
Annotated pHis sites in protein sequences are underlined. SILAC ratio (light/heavy) indicates fold enrichment of proteins by pHis mAb affinity purifi-
cation. Values from two sequential elution fractions (elution 1 [E1] and elution 2 [E2]) are reported as the median value of all quantified peptides that
correspond to the listed protein. –, not detected. See also Figure S6 and Table S1.
aRelated protein family members or isoform(s) were enriched.
bNot expressed in cell line tested.
cSequences from pHis phosphopeptides detected by MS (Lapek et al., 2015).from cell lysates prior to analysis by LC-MS/MS (Supplemental
Experimental Procedures). pNME1 and pPGAM were used to
test the pHis isomer selectivity of the high-density mAb columns.
NME1 and PGAM were phosphorylated in vitro, denatured (6 M
urea [pH 10]), mixed together, and incubated with either a 1-pHis
or 3-pHis mAb column. Purification fractions were immunoblot-
ted with 1- and 3-pHis mAbs, as well as NME1 and PGAM
antibodies, and quantification demonstrates that pNME1 was
enriched in elution fractions from the 1-pHis mAb column, while
pPGAM was enriched in elutions from the 3-pHis mAb column
(Figures S6A and S6B).
In order to determine which proteins bind the columns in a
pHis-dependent manner and which are likely false positives
that bind non-specifically, we used stable isotope labeling by
amino acids in cell culture (SILAC) to metabolically label FLAG-
NME1 293 cells. Initially, both the light- and heavy-labeled (Arg
13C6 /
15N4 and Lys
13C6) cells were lysed using identical dena-
turing and alkaline conditions (6 M urea [pH 10]) to preserve
pHis. The heavy lysates were then acidified (pH 6) and heated
at 65C for 30 min to reduce pHis. A dramatic decrease of
pHis in the heavy lysates was confirmed by immunoblotting
(data not shown). Both lysates were neutralized, diluted (1:5 to
1 M urea [pH 8]), and mixed together, and one half was passed
over the 1-pHis mAb column, while the other half was passedover the 3-pHis mAb column. LC-MS/MS analysis was per-
formed on tryptic peptides derived from proteins that eluted off
the columns at pH 11. A SILAC ratio (light/heavy) was calculated
for each peptide to determine which proteins were enriched in
the untreated, light versus heavy lysates that had been treated
to reduce pHis. We observed significant enrichment of NME1/2
(55-fold) by the 1-pHis mAb column, as well as enrichment of
PGAM (4-fold) and the other known 3-pHis proteins, including
histone H4 (22-fold) and ACLY (11-fold). Proteins corresponding
to recently identified pHis phosphopeptides (Lapek et al., 2015),
including TUBB, TCP1/CCT1, YWHAB, LDHA, RPS3A, and
GAPDH were also enriched from 5- to 11-fold (Tables 1 and
S1). In all, 630 proteins (58% of proteins quantified in 1-pHis col-
umn elutions E1–E3) and 506 proteins (54% of 3-pHis E1–E3)
were enriched by at least 2-fold (Table S1) for a total of 786
different proteins. 280 of these were unique to the 1-pHis col-
umn, and 156 were unique to the 3-pHis column. Gene ontology
analysis by biological processes (DAVID v.6.7; Huang et al.,
2009) revealed that 97 of the 786 genes are involved in cell-cycle
processes, including PP1, CDK1, cyclin B1, CUL1, and multiple
proteasome subunits. Network analysis (STRING v.9.1; France-
schini et al., 2013) was performed to visualize the protein-protein
interaction network of these cell-cycle-related genes (Fig-
ure S6C) with known pHis proteins (Table 1).Cell 162, 198–210, July 2, 2015 ª2015 Elsevier Inc. 207
DISCUSSION
Our goal was to develop tools for the study of pHis in mammalian
cells and to begin to determine its importance as a regulatory
process in normal cells and in diseases, such as cancer. Our
immunoblotting and proteomic data (Tables 1 and S1) suggest
that these mAbs can recognize pHis independent of sequence
context. However, little is known regarding the prevalence and
relative levels of pHis proteins in mammalian cells, making it un-
clear whether all pHis substrates are recognized. For example,
NME1/2 were the major cellular 1-pHis proteins detected by
the 1-pHis mAbs, but this could reflect either a sequence bias
of our 1-pHis mAbs (perhaps influenced by our screening
approach) or that abundant expression levels of NME1/2 com-
bined with their ability to autophosphorylate results in stronger
detection by immunoblotting.
As is the case with pTyr blotting, activation of specific
signaling pathways or enrichment of certain proteins by fraction-
ation or immunoprecipitation prior to immunoblotting may be
necessary to visualize low abundance, organelle-specific, or
protein substrates with low stoichiometry of phosphorylation.
The greater thermodynamic instability of 1-pHis versus 3-pHis
may also contribute to difficulty in detecting some 1-pHis pro-
teins. While detection of pNME1/2 by 1-pHis mAb immunoblot-
ting is quite heat sensitive, brief heat treatment may not be harsh
enough to reduce pHis in all proteins. There is a prominent, heat-
resistant doublet detected in most of these cell lines (Figures 5D
and 5E) that we suspect is NME4, the mitochondrial NME family
member (Figure S4B).
Striking differences were observed between 1-pHis and 3-
pHis mAb immunofluorescence staining. SC1-1 will be useful
for studying acidic compartments (i.e., phagosomes, autopha-
gosomes, and lysosomes) since staining is absent from the inte-
rior of these acidic compartments and often very bright in the
surrounding regions. Analysis of the ‘‘phagosome proteome’’
identified NME2 as an outer membrane associated phagosomal
protein (Garin et al., 2001). Dynamin-2 is required for macro-
phage phagocytosis (Gold et al., 1999), and NME1/2 were
recently shown to interact with dynamin and dynamin-induced
tubules and be required for efficient dynamin-mediated endocy-
tosis by providing a localized source of GTP (Boissan et al.,
2014). The strong 1-pHis signals we observed in regions sur-
rounding phagosomes (Figures 6A–6E) could be the local, enzy-
matic activity of NME1/2 working to replenish GTP. Alternatively,
the 1-pHis signals could reflect the presence of non-enzymatic,
pHis protein substrates that are phosphorylated by NME1/2 or
an unknown His kinase.
The 786 enriched proteins (Table S1) represent a starting point
for identification and analysis of the mammalian pHis proteome.
We preserved existing pHis on proteins in the lysates as fully as
possible (i.e., denaturing and alkaline conditions to prevent pro-
tein phosphatase driven- or acid-catalyzed hydrolysis). How-
ever, we do not yet know which conditions or stimuli induce or
increase pHis (analogous to epidermal growth factor or orthova-
nadate treatment for pTyr) to increase the yield of pHis proteins.
As it stands, themost abundant proteins with the highest stoichi-
ometry of His phosphorylation and stability are most likely to
have been observed and quantified. Therefore, the complete208 Cell 162, 198–210, July 2, 2015 ª2015 Elsevier Inc.list of pHis substrates is likely to be significantly longer than
what we have detected. The enrichment of cell-cycle proteins
by pHis mAbs is of great interest, since we also observe specific
staining of mitotic structures by 3-pHis mAbs (i.e., spindle poles,
centrosomes, andmidbodies (Figures 6F–6K and S5C–S5E) that
indicates pHis signals might be critical for regulating multiple
cell-cycle events. The 97 cell-cycle-related proteins analyzed
by STRING v.9.1 have multiple interaction nodes that fall into
seven main categories: proteasome, cytokinesis, ribosome,
cell-cycle regulation, protein phosphatase PP1, chromosome
condensation, and chromatin and spindle organization (Fig-
ure S6C). In addition, gene ontology analysis (DAVID v.6.7) by
biological processes revealed that 239 of the enriched proteins
correspond to genes involved in nucleic acid-related processes,
including (in order of p value) translation (116), translational elon-
gation (65), RNA processing (89), ribonucleoprotein complex
biogenesis (46), RNA splicing (56), and ribosome biogenesis
(35), suggesting these may also be dependent on pHis signaling.
In this regard, His phosphorylation (unlike pSer, pThr, and pTyr)
results in a positive to negative charge switch that may help
regulate binding of proteins to nucleic acids.
While these pHis mAbs are isoform specific when used for
immunoblotting and immunofluorescence, there is significant
overlap of proteins (350% or 45%) that bound to the 1-pHis
and 3-pHis mAb columns (Tables 1 and S1). We suspect that
base-catalyzed isomerization of pHis may occur under the high
pH conditions in which the proteomic experiments were per-
formed (Gonzalez-Sanchez et al., 2013).We havemade the initial
steps toward using these mAbs to study the mammalian pHis
proteome; however, there are many other cell lines and tissues
to investigate, and further optimization of our pHis mAb immu-
noaffinity purification and LC-MS/MS methods is necessary to
allow the purification of pHis phosphopeptides and direct identi-
fication of specific sites of His phosphorylation by MS.
If the mature field of phosphoester phosphorylation is any
guide, the nascent and slow-growing field of His phosphorylation
will benefit from the development of these immunological re-
agents and methods, but the development of pHis phosphatase
inhibitors and a full accounting of cellular pHis phosphatases, ki-
nases, and substrates are still missing. These mAbs will accel-
erate progress in all of these areas and help to determine the
importance of pHis in human health and disease.
EXPERIMENTAL PROCEDURES
Synthesis of 1-pTza and 3-pTza Peptides and Degenerate Peptide
Libraries
Detailed methods for chemical synthesis and analysis of the immunizing pTza
peptide libraries can be found in the Supplemental Experimental Procedures.
In general, pTza analogs were synthesized by solid-phase peptide synthesis in
accordance with published procedures (McAllister and Webb, 2012).
NME and PGAM In Vitro Phosphorylation Assays
In vitro autophosphorylation of purified NME1 and NME2 (10–30 ng/ml) was
performed by incubating in TMD buffer (20 mM Tris-HCl [pH 8.0], 5 mM
MgCl2, and 1 mM DTT) at room temperature (RT) for 10 min. Reactions were
stopped by addition of 53 sample buffer (pH 8.8) and analyzed immediately
by modified SDS-PAGE (Supplemental Experimental Procedures). Autophos-
phorylation of PGAM was performed as described for NME1, except 2,3-DPG
was used as the phosphate donor instead of ATP, and incubations were
carried out at 30C. Reactions lacking ATP or 2,3-DPG or treated briefly with
heat or acid served as negative controls. Heat treatment was performed after
the addition of 53 sample buffer (pH 8.8) for 10–15min at 95C. Acid treatment
was performed by adding 25 ml 1 N HCl to a 100 ml reaction and incubating at
37C for 15 min. Reactions were neutralized with 25 ml 1 N NaOH.
Peptide Dot Blots
Peptide dot blots were used to screen rabbit antisera titer and characterize
mAb specificity. The 1-pTza and 3-pTza peptide libraries, His control library,
and a pTyr peptide (Nck pY105) were dissolved in water at 1 mg/ml. 1:5 serial
dilutions (500, 100, 20, 5, 1, and 0.2 ng/ml) were prepared for each peptide, and
1 ml was spotted on nitrocellulose and allowed to dry for 1–2 hr at RT. Mem-
branes were blocked 1 hr at RT in casein blocking buffer (0.1% casein, 0.23
PBS/) and incubated with rabbit antisera (diluted 1:1,000 in blocking buffer
with 0.1% Tween 20) for 1 hr at RT or overnight at 4C. pTza peptide dot blots
were also used to characterize pHis mAbs. 1-pTza, 3-pTza, or His was incor-
porated into synthetic peptides of defined sequences (Supplemental Experi-
mental Procedures) from mammalian proteins with mapped pHis sites
(Table 1). Peptides were dissolved in water at 1 mg/ml. 1:5 serial dilutions
were prepared and spotted as described above.
Immunofluorescence
Primary murine macrophages were differentiated from bone marrow progeni-
tors (Zhang et al., 2008) plated on coverslips and incubated overnight in fresh
medium. Cells were incubated with 10 mg/ml Oregon Green-Dextran 488
and/or LysoTracker (50 nM) for 1–2 hr prior to fixation with 4% paraformalde-
hyde (PFA) for 10 min. Negative controls were performed by boiling slides for
5–10 min in 0.01 M citrate buffer or by pre-incubation of pHis mAbs with pTza
blocking peptides (5 mg/ml). Cells were permeabilized in blocking buffer (PBS,
5% serum [second Ab species], 2% BSA, and 0.1% Tween) with 0.1% Triton
X-100 for 1 hr at 4C. Primary antibodies were diluted to 1 mg/ml in blocking
buffer and incubated with slides for 2 hr at 4C. Slides were washed 53 with
cold PBS + 0.1% Tween and incubated with second Ab diluted 1:400 in block-
ing buffer for 1 hr at 4C. Slides were mounted on coverslips after washing 53
with cold PBS + 0.1% Tween. See also the Supplemental Experimental Proce-
dures for immunostaining of HeLa cells.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and two tables and can be found with this article online at http://
dx.doi.org/10.1016/j.cell.2015.05.046.
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